metaphit has been researched along with dextroamphetamine in 1 studies
Studies (metaphit) | Trials (metaphit) | Recent Studies (post-2010) (metaphit) | Studies (dextroamphetamine) | Trials (dextroamphetamine) | Recent Studies (post-2010) (dextroamphetamine) |
---|---|---|---|---|---|
68 | 0 | 4 | 7,044 | 697 | 660 |
Protein | Taxonomy | metaphit (IC50) | dextroamphetamine (IC50) |
---|---|---|---|
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.631 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.2884 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
French, ED; Jacobson, AE; Rice, KC | 1 |
1 other study(ies) available for metaphit and dextroamphetamine
Article | Year |
---|---|
Metaphit, a proposed phencyclidine (PCP) antagonist, prevents PCP-induced locomotor behavior through mechanisms unrelated to specific blockade of PCP receptors.
Topics: Animals; Body Weight; Brain Chemistry; Dextroamphetamine; Dopamine; Injections; Injections, Intravenous; Injections, Intraventricular; Male; Motor Activity; Nucleus Accumbens; Phencyclidine; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter; Receptors, Phencyclidine | 1987 |